EPS15 Antikörper (C-Term)
-
- Target Alle EPS15 Antikörper anzeigen
- EPS15 (Epidermal Growth Factor Receptor Pathway Substrate 15 (EPS15))
-
Bindungsspezifität
- C-Term
-
Reaktivität
- Human, Maus
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EPS15 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB)
- Spezifität
- EPS15 antibody was raised against the C terminal of EPS15
- Aufreinigung
- Affinity purified
- Immunogen
- EPS15 antibody was raised using the C terminal of EPS15 corresponding to a region with amino acids LDSPDPFKLNDPFQPFPGNDSPKEKDPEIFCDPFTSATTTTNKEADPSNF
- Top Product
- Discover our top product EPS15 Primärantikörper
-
-
- Applikationshinweise
-
WB: 1 µg/mL
Optimal conditions should be determined by the investigator. - Kommentare
-
EPS15 Blocking Peptide, catalog no. 33R-4868, is also available for use as a blocking control in assays to test for specificity of this EPS15 antibody
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of EPS15 antibody in PBS
- Konzentration
- Lot specific
- Buffer
- PBS
- Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. - Lagerung
- 4 °C/-20 °C
- Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
- Target
- EPS15 (Epidermal Growth Factor Receptor Pathway Substrate 15 (EPS15))
- Andere Bezeichnung
- EPS15 (EPS15 Produkte)
- Hintergrund
- EPS15 is a protein that is part of the EGFR pathway. The protein is present at clatherin-coated pits and is involved in receptor-mediated endocytosis of EGF. Notably, this gene is rearranged with the HRX/ALL/MLL gene in acute myelogeneous leukemias.
- Molekulargewicht
- 99 kDa (MW of target protein)
- Pathways
- EGFR Signaling Pathway, Regulation of Muscle Cell Differentiation, Skeletal Muscle Fiber Development, EGFR Downregulation
-